135 related articles for article (PubMed ID: 20351351)
1. Imaging approaches to Parkinson disease.
Brooks DJ
J Nucl Med; 2010 Apr; 51(4):596-609. PubMed ID: 20351351
[TBL] [Abstract][Full Text] [Related]
2. New developments of brain imaging for Parkinson's disease and related disorders.
Piccini P; Brooks DJ
Mov Disord; 2006 Dec; 21(12):2035-41. PubMed ID: 16874751
[TBL] [Abstract][Full Text] [Related]
3. Can we image premotor Parkinson disease?
Marek K; Jennings D
Neurology; 2009 Feb; 72(7 Suppl):S21-6. PubMed ID: 19221310
[TBL] [Abstract][Full Text] [Related]
4. Imaging neurodegeneration in Parkinson's disease.
Pavese N; Brooks DJ
Biochim Biophys Acta; 2009 Jul; 1792(7):722-9. PubMed ID: 18992326
[TBL] [Abstract][Full Text] [Related]
5. Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging.
Eckert T; Feigin A; Lewis DE; Dhawan V; Frucht S; Eidelberg D
Mov Disord; 2007 Jan; 22(2):167-73. PubMed ID: 17133454
[TBL] [Abstract][Full Text] [Related]
6. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.
Booij J; Bergmans P; Winogrodzka A; Speelman JD; Wolters EC
Synapse; 2001 Feb; 39(2):101-8. PubMed ID: 11180497
[TBL] [Abstract][Full Text] [Related]
7. The role of structural and functional imaging in parkinsonian states with a description of PET technology.
Brooks DJ
Semin Neurol; 2008 Sep; 28(4):435-45. PubMed ID: 18843572
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease: diagnosis.
Brooks DJ
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S31-3. PubMed ID: 22166447
[TBL] [Abstract][Full Text] [Related]
9. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
Kish SJ; Tong J; Hornykiewicz O; Rajput A; Chang LJ; Guttman M; Furukawa Y
Brain; 2008 Jan; 131(Pt 1):120-31. PubMed ID: 17956909
[TBL] [Abstract][Full Text] [Related]
10. [PET and SPECT in Parkinson's disease].
Blesa R
Rev Neurol; 1997 Aug; 25 Suppl 2():S147-50. PubMed ID: 9280681
[TBL] [Abstract][Full Text] [Related]
11. Functional imaging in Parkinson disease.
Nandhagopal R; McKeown MJ; Stoessl AJ
Neurology; 2008 Apr; 70(16 Pt 2):1478-88. PubMed ID: 18413571
[TBL] [Abstract][Full Text] [Related]
12. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
13. Neuroimaging in Parkinson's disease: from pathology to diagnosis.
Stoessl AJ
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S55-9. PubMed ID: 22166455
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound in the (premotor) diagnosis of Parkinson's disease.
Berg D
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S429-33. PubMed ID: 18267277
[TBL] [Abstract][Full Text] [Related]
15. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
[TBL] [Abstract][Full Text] [Related]
16. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity.
Hilker R; Schweitzer K; Coburger S; Ghaemi M; Weisenbach S; Jacobs AH; Rudolf J; Herholz K; Heiss WD
Arch Neurol; 2005 Mar; 62(3):378-82. PubMed ID: 15767502
[TBL] [Abstract][Full Text] [Related]
17. Imaging biomarkers in Parkinson's disease.
Brooks DJ; Pavese N
Prog Neurobiol; 2011 Dec; 95(4):614-28. PubMed ID: 21896306
[TBL] [Abstract][Full Text] [Related]
18. [Recent advances in imaging in Parkinson disease].
Baba T; Takeda A
Brain Nerve; 2012 Apr; 64(4):423-32. PubMed ID: 22481515
[TBL] [Abstract][Full Text] [Related]
19. Technology insight: imaging neurodegeneration in Parkinson's disease.
Brooks DJ
Nat Clin Pract Neurol; 2008 May; 4(5):267-77. PubMed ID: 18382437
[TBL] [Abstract][Full Text] [Related]
20. Neuroimaging: current role in detecting pre-motor Parkinson's disease.
Godau J; Hussl A; Lolekha P; Stoessl AJ; Seppi K
Mov Disord; 2012 Apr; 27(5):634-43. PubMed ID: 22508281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
